XJPX
4076
Market cap36mUSD
Oct 09, Last price
1,958.00JPY
1D
-1.16%
1Q
13.84%
IPO
-19.06%
Name
CNS Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Operating across Japan with its subsidiaries, CNS Co.,Ltd. specializes in delivering a comprehensive suite of system engineering solutions. Its offerings include robust system integration services, encompassing the establishment of cloud and infrastructure environments, bespoke application development, system modernization initiatives, data utilization and advanced analytics, alongside expert support for SAS and ServiceNow implementations. The company also provides specialized cloud infrastructure solutions, such as U-Way Oracle Cloud Infrastructure, U-Way Oracle Cloud VMware Solution, and the U-Way Lite OCI base model. Further expanding its portfolio, CNS offers strategic consulting in digital transformation (DX), technology, and business, in addition to services focused on system infrastructure management, big data analysis, and the promotion of digital innovation. They also facilitate client growth through DX literacy education and human resource development accompaniment support. Established in 1985, CNS Co.,Ltd. is headquartered in Tokyo, Japan.
Key people
Hiroya Aihara
Senior Executive Officer · since 2025
Takashi Furuto
Senior Executive Officer · since 2025
Seiichi Kimura
Senior Executive Officer · since 2025
Haruhiko Onoma
Senior Executive Officer · since 2025
Mitsutoshi Yasuda
Executive Officer · since 2025
Masatoshi Inoko
Senior Director of Business Administration, Chief Director of Corporate, Director · since 2024
Kazuhiro Maeda
Chief Director of technology Business, Director · since 2025
Hidehiko Miyagawa
Director · since 2022
Hideaki Fukuda
Independent Director · since 2022
Takayuki Hotta
Independent Director · since 2022
Reiko Iwao
Independent Director · since 2025
Noriaki Onishi
Independent Director · since 2023
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2026‑05 | 2025‑05 | 2024‑05 | 2023‑05 | 2022‑05 | 2021‑05 | 2020‑05 | 2019‑05 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||